Mendelian Randomization Studies in Atherosclerotic Cardiovascular Diseases

Area of Science:

• Cardiovascular Science
• Genetics
• Epidemiology

Background:

• Atherosclerotic cardiovascular disease (ASCVD) research faces challenges due to confounding factors in traditional studies.
• Observational and randomized controlled trials have limitations in establishing causality.
• Mendelian randomization (MR) offers a robust alternative for causal inference in ASCVD.

Purpose of the Study:

• To highlight the critical role of Mendelian randomization (MR) in advancing atherosclerotic cardiovascular disease (ASCVD) research.
• To elucidate the causal relationship between low-density lipoprotein cholesterol and ASCVD using MR.
• To discuss the assumptions, nuances, and ethical considerations of MR in ASCVD.

Main Methods:

• Utilizing genetic variants as instrumental variables to infer causality.
• Analyzing methodological aspects of MR, including instrumental variable selection and pleiotropy.
• Reviewing existing literature on MR applications in ASCVD research.

Main Results:

• MR provides robust causal insights into ASCVD, particularly for lipid-related factors like low-density lipoprotein cholesterol.
• The method effectively bypasses confounding and biases inherent in traditional study designs.
• Discussion of pleiotropy and ethical considerations provides a balanced view of MR's application.

Conclusions:

• Mendelian randomization is a transformative tool for ASCVD research, enhancing causal understanding.
• Integration of MR with new technologies and data sharing holds promise for personalized medicine.
• This review serves as a resource for improved ASCVD understanding and targeted interventions.